A Leviton1, O Dammann. 1. Department of Neurology, Children's Hospital, Boston, MA 02115, USA. alan.leviton@tch.harvard.edu
Abstract
UNLABELLED: The presence in blood of proteins normally confined to the cytoplasm of brain cells is considered peripheral evidence of brain damage. Only recently have these proteins been measured in the blood of children at risk of brain damage. To show the value and limitations of measuring these proteins, we review their biology and the adult literature that has correlated the blood concentrations of these proteins with lesion size and dysfunction. CONCLUSION: We conclude that brain damage markers will increasingly be measured in the blood of newborns and other children at risk of brain damage.
UNLABELLED: The presence in blood of proteins normally confined to the cytoplasm of brain cells is considered peripheral evidence of brain damage. Only recently have these proteins been measured in the blood of children at risk of brain damage. To show the value and limitations of measuring these proteins, we review their biology and the adult literature that has correlated the blood concentrations of these proteins with lesion size and dysfunction. CONCLUSION: We conclude that brain damage markers will increasingly be measured in the blood of newborns and other children at risk of brain damage.
Authors: Luciano K Jornada; Gustavo Feier; Tatiana Barichello; Angeles M Vitali; Adalisa Reinke; Elaine C Gavioli; Felipe Dal-Pizzol; João Quevedo Journal: Neurochem Res Date: 2007-03 Impact factor: 3.996
Authors: Robert Siman; Victoria L Roberts; Elizabeth McNeil; Antony Dang; Joseph E Bavaria; Sindhu Ramchandren; Michael McGarvey Journal: Brain Res Date: 2008-04-01 Impact factor: 3.252
Authors: Jay Jagannathan; Jie Li; Nicholas Szerlip; Alexander O Vortmeyer; Russell R Lonser; Edward H Oldfield; Zhengping Zhuang Journal: Neurosurgery Date: 2009-01 Impact factor: 4.654